Harpreet Singh
Chief Executive Officer at Immatics
- Role
- Board Member (Executive Director) at Immatics
- Location
- Houston, TX, US
- LinkedIn followers
- 500 followers
About Harpreet Singh
Dr. Harpreet Singh is Co-Founder, Chief Executive Officer and Member of the Board at Immatics (NASDAQ: IMTX), a clinical-stage biotechnology company and the global leader in precision targeting of PRAME. PRAME is a target expressed in more than 50 cancers and Immatics has the broadest PRAME franchise with the most PRAME indications and modalities, spanning cell therapies and bispecifics.Dr. Harpreet Singh brings together leadership experience, scientific expertise and innovation in T-cell based immunotherapy of advanced solid cancers. He has played a critical role in developing Immatics from a start-up into a global, publicly listed biopharma enterprise, leading a team of more than 500 people based in the US and Germany, committed to making a meaningful impact on the lives of patients with cancer.Dr. Singh holds a PhD in immunology from the University of Tuebingen, Germany.
Experience
Board Member (Executive Director)
Jul 2021 — Present
Education
University of Tübingen
PhD, Immunology
1999 — 2002
Technische Universität Darmstadt
Bachelor's degree (Pre-Diploma), Chemistry
1993 — 1995
University of Tübingen
Master's degree (Diploma), Biochemistry
1995 — 1999
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.